Preliminary findings suggest that the administration of repeated doses of intradermal heat‐killed Mycobacterium indicus pranii (formerly known as Mycobacterium w) immunotherapy holds promise in reducing inflammation associated with TB and increasing CD4 + T‐cell count in individuals with HIV infection.14, 15, 16. Here, CD4 is linked to tuberculosis.